Alivus Life Sciences Limited (NSE:ALIVUS)
India
· Delayed Price · Currency is INR 1,001.30
+6.70 (0.67%)
At close: Jun 27, 2025, 3:30 PM IST
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 123.22 billion as of June 27, 2025. Its market cap has increased by 22.27% in one year.
Market Cap
123.22B
Enterprise Value
118.30B
Revenue
23.87B
Ranking
n/a
PE Ratio
25.43
Stock Price
1,001.30
Market Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 123.22B, an increase of 34.35%. That is a compound annual growth rate of 7.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 123.22B | 2.25% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,006.41B |
| Divi's Laboratories | 1,748.51B |
| Cipla | 1,222.71B |
| Apollo Hospitals Enterprise | 1,012.53B |
| Zydus Lifesciences | 988.07B |
| Mankind Pharma | 952.91B |
| Aurobindo Pharma | 650.61B |
| Fortis Healthcare | 588.72B |